Mark Mathis
Chairman
Mark Mathis has served as Free Flow Medical’s Chairman of the Board of Directors, President and CEO since founding the company in 2017 while also serving as a member of the Compensation Committee.
Prior to founding Free Flow Medical, Mark was founder and Chief Technology Officer at PneumRx (Acquired by British Technology Group) where he led technology advancements in pulmonary medicine beginning in 2003.
Mark previously founded Genesis Medical (Acquired by Boston Scientific) and Cardiac Dimensions and he led product development at NDC (Acquired by JNJ/Cordis) and Kera Vision. Mark is a named inventor on 110 granted US patents.
Mr. Mathis received a B.S. in Mechanical Engineering from California State University, Chico and attended graduate course work at Clemson University, SC.
David Paul
Director
David Paul has served on our Board of Directors since February 2019 and is a member of our Compensation Committee.
David is the Executive Chairman of Globus Medical where he served as Chief Executive Officer from the company’s inception in 2003 until August 2017, when he transitioned into the role of Executive Chairman.
Prior to founding Globus, Mr. Paul was employed at Synthes in various positions. Mr. Paul served as Director of Product Development for Synthes in his last position, where he was responsible for product development and marketing functions.
Prior to Synthes, Mr. Paul worked as a Research Engineer in biomaterials research at Temple University. Mr. Paul is named inventor on approximately 225 patents and published applications.
Mr. Paul received a B.S. in Mechanical Engineering from the University of Madras, and an M.S. in Computer Integrated Mechanical Engineering Systems from Temple University.
Kim Mathis
Director
Kim Mathis has served as Free Flow Medical’s Chief Financial Officer and company Board Member since founding the company in December 2017 while also serving as a member of the Compensation Committee.
Prior to founding Free Flow Medical, Kim held leadership roles with major financial institutions including Allianz, Liberty Mutual and Travelers.
Ms. Mathis graduated from Trinity University in San Antonio, Texas, with a B.S. in Business Administration and attained CPCU and ARM designations.
Kurt Wheeler
Investor
Mr. Wheeler was a co-founder and Managing Director of a leading global life sciences investment firm that raised $2.6 billion since its founding.
Mr. Wheeler has over 30 years of direct investment and industry operating experience within the healthcare sector where he has led investments in the medical technology, specialty pharmaceutical, and biotechnology space including partnerships with pharmaceutical companies.
Mr. Wheeler was a General Partner at MPM Capital, a healthcare venture capital firm. Mr. Wheeler was also a co-founder and CEO of InControl, a medical device company which he sold to Guidant.
Mr. Wheeler holds a BA from Brigham Young University and an MBA from Northwestern University’s Kellogg School.
